טוען...
Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents
OBJECTIVES: Anaemia is the most common side effect associated with ribavirin (RBV). This study intended to assess its incidence and determine its predictive factors in patients with hepatitis C virus on RBV plus direct-acting antiviral agents (DAAs). METHODS: A retrospective study of patients receiv...
שמור ב:
| הוצא לאור ב: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
European Journal of Hospital Pharmacy
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452397/ https://ncbi.nlm.nih.gov/pubmed/31157007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2017-001277 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|